Showing results (81-90 of 279) with videos related to
Sort By:
Pageof 28
Cancer Research|September 3, 2010
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancerMeng-Lei Zhu, Craig M Horbinski, Mark Garzotto, et al.Cancer|July 20, 2007
Diethylstilbestrol and docetaxel: a Phase II study of tubulin active agents in patients with metastatic, androgen-independent prostate cancerR Bruce Montgomery, Peter S Nelson, Daniel Lin, et al.BJUI Compass|October 21, 2022
Functional impact of androgen-targeted therapy on patients with castration-resistant prostate cancerTomasz M Beer, Neal Shore, Alicia Morgans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.The Journal of Biological Chemistry|September 16, 2011
HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxiaHao Geng, Chris T Harvey, Janet Pittsenbarger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumorsGayathri R Devi, Tomasz M Beer, Christopher L Corless, et al.The Journal of Urology|March 27, 2007
Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes studyJulie N Graff, Motomi Mori, Hong Li, et al.American Journal of Clinical Pathology|March 17, 2010
Histologic changes associated with neoadjuvant chemotherapy are predictive of nodal metastases in patients with high-risk prostate cancerCatherine O'Brien, Lawrence D True, Celestia S Higano, et al.Urology|July 28, 2007
Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapyChristopher W Ryan, Dezheng Huo, James W Stallings, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Effect of calcitriol on prostate-specific antigen in vitro and in humansTomasz M Beer, Mark Garzotto, Byung Park, et al.Pageof 28